Principal Investigator Of Suspended Cytori Stem Cell Trials Remains Hopeful – Forbes
|
Principal Investigator Of Suspended Cytori Stem Cell Trials Remains Hopeful
Forbes Shares of Cytori Therapeutics took a big bit hit today after the company disclosed in a press release that it had suspended enrollment in its ATHENA and ATHENA II trials. This kind of news is never a good sign, but the principal investigator of the … Cytori shares slammed as safety concerns halt stem cell trials Cytori halts stem cell study due to adverse events |
